Kazia Therapeutics (KZIA) Receivables - Net (2017 - 2025)

Kazia Therapeutics (KZIA) has disclosed Receivables - Net for 6 consecutive years, with $62762.5 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Receivables - Net fell 97.56% year-over-year to $62762.5, compared with a TTM value of $62762.5 through Jun 2025, down 97.56%, and an annual FY2025 reading of $63516.7, down 97.51% over the prior year.
  • Receivables - Net was $62762.5 for Q2 2025 at Kazia Therapeutics, down from $2.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $2.6 million in Q2 2024 and bottomed at $668.36 in Q2 2023.
  • Average Receivables - Net over 4 years is $674207.4, with a median of $63971.4 recorded in 2022.
  • The sharpest move saw Receivables - Net tumbled 98.97% in 2023, then skyrocketed 384156.49% in 2024.
  • Year by year, Receivables - Net stood at $65180.4 in 2022, then crashed by 98.97% to $668.36 in 2023, then surged by 384156.49% to $2.6 million in 2024, then plummeted by 97.56% to $62762.5 in 2025.
  • Business Quant data shows Receivables - Net for KZIA at $62762.5 in Q2 2025, $2.6 million in Q2 2024, and $668.36 in Q2 2023.